Medical Shift: PCOS Renamed PMOS to Reflect Metabolic, Not Just Reproductive, Disorder

For decades, a condition affecting millions of women carried a name that pointed doctors and patients in the wrong direction. Polycystic Ovary Syndrome—PCOS—suggested the problem lived in the ovaries, a reproductive issue to be managed by gynecologists. But the condition was never that simple, and the medical community has now formally acknowledged it. The syndrome is being renamed Polyendocrine Metabolic Ovarian Syndrome, or PMOS, a shift that eight leading physicians across India's major hospital systems say is overdue and consequential.

The change reflects a fundamental reframing of what the condition actually is. PMOS is a whole-body disorder affecting hormones, metabolism, insulin sensitivity, cardiovascular health, and mental wellbeing—not merely a reproductive concern. The old name created a blind spot. Patients and doctors alike focused narrowly on ovarian cysts and fertility, while metabolic dangers accumulated silently: insulin resistance, type 2 diabetes, fatty liver disease, cardiovascular complications. Dr. David Chandy, Director of Endocrinology and Diabetology at Sir HN Reliance Foundation Hospital, noted that many people assumed the condition involved only ovarian cysts, a medically inaccurate understanding. In fact, many women with PMOS have no cysts at all. What appear as cysts are actually immature ovarian follicles that fail to rupture and accumulate along the ovary's outer layer, disrupting hormonal balance.

Diagnosis under the new framework is far more comprehensive. Rather than relying primarily on ultrasound imaging, physicians now screen for insulin resistance, glucose tolerance, lipid profiles, hormone levels, body composition, and metabolic markers. Dr. Nidhi Rajotia, Unit Head of Obstetrics and Gynaecology at Artemis Hospitals, explained that evaluation includes menstrual history, signs of hormonal imbalance, blood pressure, waist circumference, and lifestyle factors—diet, exercise, sleep, and stress—because of PMOS's strong metabolic link. Diagnosis still follows established criteria: two of three features are required, such as irregular periods or ovulatory dysfunction, clinical or biochemical signs of elevated androgens (acne, excess facial hair, hair loss, or elevated testosterone levels), and ultrasound evidence of polycystic ovaries showing a characteristic "string of pearls" appearance.

The misconceptions surrounding the condition run deep, and experts are working to dismantle them. One persistent myth holds that only overweight women develop PMOS. In reality, lean women can have the condition and experience significant insulin resistance. Another false belief is that ovarian cysts are necessary for diagnosis—some women with PMOS have no cysts, while some women with polycystic ovaries do not have the syndrome. A third misconception, perhaps the most damaging, is that PMOS affects only fertility and menstrual cycles. The condition impacts metabolism, skin health, mood, body weight, and cardiovascular health while increasing diabetes risk. Early warning signs that women often dismiss as stress or normal body changes include menstrual cycles longer than 35 days, persistent acne around the jawline and neck, unexplained abdominal weight gain, excess facial hair, hair thinning, and fatigue or sleep disturbances.

Management now requires a multidisciplinary approach. Gynecologists, endocrinologists, dermatologists, nutritionists, and mental health professionals work together to address the condition's multiple dimensions. Some supplements show promise—myo-inositol, omega-3 fatty acids, vitamin D, and NAC may help improve insulin sensitivity, hormone balance, and fertility—but Dr. Preeti Rastogi, Director and Head of the Institute of Obstetrics and Gynaecology at Medanta, cautioned that many online supplements lack scientific evidence and self-medication can interfere with prescribed treatments. Experts warn against unregulated "hormone balance" teas, detox products, and herbal blends without clinical proof.

Regarding fertility, the experts stressed that PMOS does not mean infertility. The condition mainly affects ovulation timing and egg release, but many women conceive naturally while others benefit from ovulation-inducing medications or IVF. Weight loss can improve symptoms and restore ovulation in many women, though it is not a universal cure, particularly for lean women with PMOS driven by different hormonal pathways. The renaming and reconceptualization of the condition signals a shift toward earlier detection, more accurate diagnosis, and treatment that addresses the full scope of metabolic and endocrine dysfunction rather than focusing narrowly on reproductive outcomes.